Home Healthcare Medical Devices Hemoglobinopathies Market

Hemoglobinopathies Market Size, Share & Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease, Hemoglobin C disease, Hemoglobin E disease, Others), By Treatment Type (Blood Transfusion, Gene Therapy, Stem Cell Transplant, Pharmacotherapy, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 22, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Hemoglobinopathies Market Size Analysis
    1. Introduction
    2. Hemoglobinopathies Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Thalassemia
      2. Sickle Cell Disease
      3. Hemoglobin C disease
      4. Hemoglobin E disease
      5. Others
    3. Hemoglobinopathies Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Blood Transfusion
      2. Gene Therapy
      3. Stem Cell Transplant
      4. Pharmacotherapy
      5. Others
    4. Hemoglobinopathies Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
  7. North America Hemoglobinopathies Market Size Analysis
    1. Introduction
    2. Hemoglobinopathies Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Thalassemia
      2. Sickle Cell Disease
      3. Hemoglobin C disease
      4. Hemoglobin E disease
      5. Others
    3. Hemoglobinopathies Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Blood Transfusion
      2. Gene Therapy
      3. Stem Cell Transplant
      4. Pharmacotherapy
      5. Others
    4. Hemoglobinopathies Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
  8. Europe Hemoglobinopathies Market Size Analysis
    1. Introduction
    2. Hemoglobinopathies Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Thalassemia
      2. Sickle Cell Disease
      3. Hemoglobin C disease
      4. Hemoglobin E disease
      5. Others
    3. Hemoglobinopathies Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Blood Transfusion
      2. Gene Therapy
      3. Stem Cell Transplant
      4. Pharmacotherapy
      5. Others
    4. Hemoglobinopathies Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
  9. APAC Hemoglobinopathies Market Size Analysis
    1. Introduction
    2. Hemoglobinopathies Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Thalassemia
      2. Sickle Cell Disease
      3. Hemoglobin C disease
      4. Hemoglobin E disease
      5. Others
    3. Hemoglobinopathies Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Blood Transfusion
      2. Gene Therapy
      3. Stem Cell Transplant
      4. Pharmacotherapy
      5. Others
    4. Hemoglobinopathies Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
  10. Middle East and Africa Hemoglobinopathies Market Size Analysis
    1. Introduction
    2. Hemoglobinopathies Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Thalassemia
      2. Sickle Cell Disease
      3. Hemoglobin C disease
      4. Hemoglobin E disease
      5. Others
    3. Hemoglobinopathies Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Blood Transfusion
      2. Gene Therapy
      3. Stem Cell Transplant
      4. Pharmacotherapy
      5. Others
    4. Hemoglobinopathies Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
  11. LATAM Hemoglobinopathies Market Size Analysis
    1. Introduction
    2. Hemoglobinopathies Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Thalassemia
      2. Sickle Cell Disease
      3. Hemoglobin C disease
      4. Hemoglobin E disease
      5. Others
    3. Hemoglobinopathies Market Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
      1. Blood Transfusion
      2. Gene Therapy
      3. Stem Cell Transplant
      4. Pharmacotherapy
      5. Others
    4. Hemoglobinopathies Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Ambulatory Surgical Centers
      4. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Thalassemia
        2. Sickle Cell Disease
        3. Hemoglobin C disease
        4. Hemoglobin E disease
        5. Others
      3. Market Size & Forecast By Treatment Type 2022-2034 (USD MILLION/ Units)
        1. Blood Transfusion
        2. Gene Therapy
        3. Stem Cell Transplant
        4. Pharmacotherapy
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Ambulatory Surgical Centers
        4. Others
  12. Competitive Landscape
    1. Hemoglobinopathies Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Sangamo Therapeutics, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Global Blood Therapeutics, Inc.
    3. bluebird bio, Inc.
    4. Emmaus Life Sciences Inc.
    5. Pfizer, Inc.
    6. Novartis AG
    7. Prolong Pharmaceuticals, LLC
    8. Bioverativ Inc.
    9. Gamida Cell
    10. Celgene Corporation
    11. Alnylam Pharmaceuticals, Inc.
    12. Merck & Co. Inc.
    13. Biogen Inc.
    14. CRISPR Therapeutics
    15. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.